Global Faecal Microbiota Transplant(FMT) Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Faecal Microbiota Transplant(FMT) Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Faecal Microbiota Transplant(FMT) Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Faecal Microbiota Transplant(FMT) Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Faecal Microbiota Transplant(FMT) Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Faecal Microbiota Transplant(FMT) Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Faecal Microbiota Transplant(FMT) Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Faecal Microbiota Transplant(FMT) Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Faecal Microbiota Transplant(FMT) Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Enterome Bioscience, Rebiotix, Ritter Pharmaceuticals, Finch Therapeutics and Crestovo, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Faecal Microbiota Transplant(FMT) Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Faecal Microbiota Transplant(FMT) Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Faecal Microbiota Transplant(FMT) Therapy, with revenue, gross margin and global market share of Faecal Microbiota Transplant(FMT) Therapy from 2018 to 2023.
Chapter 3, the Faecal Microbiota Transplant(FMT) Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Faecal Microbiota Transplant(FMT) Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Faecal Microbiota Transplant(FMT) Therapy.
Chapter 13, to describe Faecal Microbiota Transplant(FMT) Therapy research findings and conclusion.
This report is a detailed and comprehensive analysis for global Faecal Microbiota Transplant(FMT) Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Faecal Microbiota Transplant(FMT) Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Faecal Microbiota Transplant(FMT) Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Faecal Microbiota Transplant(FMT) Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Faecal Microbiota Transplant(FMT) Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Faecal Microbiota Transplant(FMT) Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Faecal Microbiota Transplant(FMT) Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Enterome Bioscience, Rebiotix, Ritter Pharmaceuticals, Finch Therapeutics and Crestovo, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Faecal Microbiota Transplant(FMT) Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Oral
- Enema
- Clostridioides Difficile Infection(CDI)
- Digestive System Disease
- Nervous System Disease
- Others
- Enterome Bioscience
- Rebiotix
- Ritter Pharmaceuticals
- Finch Therapeutics
- Crestovo
- Maat Pharma
- Seres Therapeutics
- Second Genome
- OpenBiome
- MicroBiome Therapeutics
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Faecal Microbiota Transplant(FMT) Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Faecal Microbiota Transplant(FMT) Therapy, with revenue, gross margin and global market share of Faecal Microbiota Transplant(FMT) Therapy from 2018 to 2023.
Chapter 3, the Faecal Microbiota Transplant(FMT) Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Faecal Microbiota Transplant(FMT) Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Faecal Microbiota Transplant(FMT) Therapy.
Chapter 13, to describe Faecal Microbiota Transplant(FMT) Therapy research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Faecal Microbiota Transplant(FMT) Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Faecal Microbiota Transplant(FMT) Therapy by Type
1.3.1 Overview: Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Type in 2022
1.3.3 Oral
1.3.4 Enema
1.4 Global Faecal Microbiota Transplant(FMT) Therapy Market by Application
1.4.1 Overview: Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Clostridioides Difficile Infection(CDI)
1.4.3 Digestive System Disease
1.4.4 Nervous System Disease
1.4.5 Others
1.5 Global Faecal Microbiota Transplant(FMT) Therapy Market Size & Forecast
1.6 Global Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast by Region
1.6.1 Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Region, (2018-2029)
1.6.3 North America Faecal Microbiota Transplant(FMT) Therapy Market Size and Prospect (2018-2029)
1.6.4 Europe Faecal Microbiota Transplant(FMT) Therapy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size and Prospect (2018-2029)
1.6.6 South America Faecal Microbiota Transplant(FMT) Therapy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Faecal Microbiota Transplant(FMT) Therapy Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Enterome Bioscience
2.1.1 Enterome Bioscience Details
2.1.2 Enterome Bioscience Major Business
2.1.3 Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
2.1.4 Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Enterome Bioscience Recent Developments and Future Plans
2.2 Rebiotix
2.2.1 Rebiotix Details
2.2.2 Rebiotix Major Business
2.2.3 Rebiotix Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
2.2.4 Rebiotix Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Rebiotix Recent Developments and Future Plans
2.3 Ritter Pharmaceuticals
2.3.1 Ritter Pharmaceuticals Details
2.3.2 Ritter Pharmaceuticals Major Business
2.3.3 Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
2.3.4 Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Ritter Pharmaceuticals Recent Developments and Future Plans
2.4 Finch Therapeutics
2.4.1 Finch Therapeutics Details
2.4.2 Finch Therapeutics Major Business
2.4.3 Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
2.4.4 Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Finch Therapeutics Recent Developments and Future Plans
2.5 Crestovo
2.5.1 Crestovo Details
2.5.2 Crestovo Major Business
2.5.3 Crestovo Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
2.5.4 Crestovo Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Crestovo Recent Developments and Future Plans
2.6 Maat Pharma
2.6.1 Maat Pharma Details
2.6.2 Maat Pharma Major Business
2.6.3 Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
2.6.4 Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Maat Pharma Recent Developments and Future Plans
2.7 Seres Therapeutics
2.7.1 Seres Therapeutics Details
2.7.2 Seres Therapeutics Major Business
2.7.3 Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
2.7.4 Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Seres Therapeutics Recent Developments and Future Plans
2.8 Second Genome
2.8.1 Second Genome Details
2.8.2 Second Genome Major Business
2.8.3 Second Genome Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
2.8.4 Second Genome Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Second Genome Recent Developments and Future Plans
2.9 OpenBiome
2.9.1 OpenBiome Details
2.9.2 OpenBiome Major Business
2.9.3 OpenBiome Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
2.9.4 OpenBiome Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 OpenBiome Recent Developments and Future Plans
2.10 MicroBiome Therapeutics
2.10.1 MicroBiome Therapeutics Details
2.10.2 MicroBiome Therapeutics Major Business
2.10.3 MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
2.10.4 MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 MicroBiome Therapeutics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Faecal Microbiota Transplant(FMT) Therapy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Faecal Microbiota Transplant(FMT) Therapy by Company Revenue
3.2.2 Top 3 Faecal Microbiota Transplant(FMT) Therapy Players Market Share in 2022
3.2.3 Top 6 Faecal Microbiota Transplant(FMT) Therapy Players Market Share in 2022
3.3 Faecal Microbiota Transplant(FMT) Therapy Market: Overall Company Footprint Analysis
3.3.1 Faecal Microbiota Transplant(FMT) Therapy Market: Region Footprint
3.3.2 Faecal Microbiota Transplant(FMT) Therapy Market: Company Product Type Footprint
3.3.3 Faecal Microbiota Transplant(FMT) Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value and Market Share by Type (2018-2023)
4.2 Global Faecal Microbiota Transplant(FMT) Therapy Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Application (2018-2023)
5.2 Global Faecal Microbiota Transplant(FMT) Therapy Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2018-2029)
6.2 North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2018-2029)
6.3 North America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country
6.3.1 North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Country (2018-2029)
6.3.2 United States Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
6.3.3 Canada Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
6.3.4 Mexico Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2018-2029)
7.2 Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2018-2029)
7.3 Europe Faecal Microbiota Transplant(FMT) Therapy Market Size by Country
7.3.1 Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Country (2018-2029)
7.3.2 Germany Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
7.3.3 France Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
7.3.5 Russia Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
7.3.6 Italy Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size by Region
8.3.1 Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Region (2018-2029)
8.3.2 China Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
8.3.3 Japan Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
8.3.4 South Korea Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
8.3.5 India Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
8.3.7 Australia Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2018-2029)
9.2 South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2018-2029)
9.3 South America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country
9.3.1 South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Country (2018-2029)
9.3.2 Brazil Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
9.3.3 Argentina Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Size by Country
10.3.1 Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Country (2018-2029)
10.3.2 Turkey Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
10.3.4 UAE Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Faecal Microbiota Transplant(FMT) Therapy Market Drivers
11.2 Faecal Microbiota Transplant(FMT) Therapy Market Restraints
11.3 Faecal Microbiota Transplant(FMT) Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Faecal Microbiota Transplant(FMT) Therapy Industry Chain
12.2 Faecal Microbiota Transplant(FMT) Therapy Upstream Analysis
12.3 Faecal Microbiota Transplant(FMT) Therapy Midstream Analysis
12.4 Faecal Microbiota Transplant(FMT) Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Faecal Microbiota Transplant(FMT) Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Faecal Microbiota Transplant(FMT) Therapy by Type
1.3.1 Overview: Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Type in 2022
1.3.3 Oral
1.3.4 Enema
1.4 Global Faecal Microbiota Transplant(FMT) Therapy Market by Application
1.4.1 Overview: Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Clostridioides Difficile Infection(CDI)
1.4.3 Digestive System Disease
1.4.4 Nervous System Disease
1.4.5 Others
1.5 Global Faecal Microbiota Transplant(FMT) Therapy Market Size & Forecast
1.6 Global Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast by Region
1.6.1 Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Region, (2018-2029)
1.6.3 North America Faecal Microbiota Transplant(FMT) Therapy Market Size and Prospect (2018-2029)
1.6.4 Europe Faecal Microbiota Transplant(FMT) Therapy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size and Prospect (2018-2029)
1.6.6 South America Faecal Microbiota Transplant(FMT) Therapy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Faecal Microbiota Transplant(FMT) Therapy Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Enterome Bioscience
2.1.1 Enterome Bioscience Details
2.1.2 Enterome Bioscience Major Business
2.1.3 Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
2.1.4 Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Enterome Bioscience Recent Developments and Future Plans
2.2 Rebiotix
2.2.1 Rebiotix Details
2.2.2 Rebiotix Major Business
2.2.3 Rebiotix Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
2.2.4 Rebiotix Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Rebiotix Recent Developments and Future Plans
2.3 Ritter Pharmaceuticals
2.3.1 Ritter Pharmaceuticals Details
2.3.2 Ritter Pharmaceuticals Major Business
2.3.3 Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
2.3.4 Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Ritter Pharmaceuticals Recent Developments and Future Plans
2.4 Finch Therapeutics
2.4.1 Finch Therapeutics Details
2.4.2 Finch Therapeutics Major Business
2.4.3 Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
2.4.4 Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Finch Therapeutics Recent Developments and Future Plans
2.5 Crestovo
2.5.1 Crestovo Details
2.5.2 Crestovo Major Business
2.5.3 Crestovo Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
2.5.4 Crestovo Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Crestovo Recent Developments and Future Plans
2.6 Maat Pharma
2.6.1 Maat Pharma Details
2.6.2 Maat Pharma Major Business
2.6.3 Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
2.6.4 Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Maat Pharma Recent Developments and Future Plans
2.7 Seres Therapeutics
2.7.1 Seres Therapeutics Details
2.7.2 Seres Therapeutics Major Business
2.7.3 Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
2.7.4 Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Seres Therapeutics Recent Developments and Future Plans
2.8 Second Genome
2.8.1 Second Genome Details
2.8.2 Second Genome Major Business
2.8.3 Second Genome Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
2.8.4 Second Genome Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Second Genome Recent Developments and Future Plans
2.9 OpenBiome
2.9.1 OpenBiome Details
2.9.2 OpenBiome Major Business
2.9.3 OpenBiome Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
2.9.4 OpenBiome Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 OpenBiome Recent Developments and Future Plans
2.10 MicroBiome Therapeutics
2.10.1 MicroBiome Therapeutics Details
2.10.2 MicroBiome Therapeutics Major Business
2.10.3 MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
2.10.4 MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 MicroBiome Therapeutics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Faecal Microbiota Transplant(FMT) Therapy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Faecal Microbiota Transplant(FMT) Therapy by Company Revenue
3.2.2 Top 3 Faecal Microbiota Transplant(FMT) Therapy Players Market Share in 2022
3.2.3 Top 6 Faecal Microbiota Transplant(FMT) Therapy Players Market Share in 2022
3.3 Faecal Microbiota Transplant(FMT) Therapy Market: Overall Company Footprint Analysis
3.3.1 Faecal Microbiota Transplant(FMT) Therapy Market: Region Footprint
3.3.2 Faecal Microbiota Transplant(FMT) Therapy Market: Company Product Type Footprint
3.3.3 Faecal Microbiota Transplant(FMT) Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value and Market Share by Type (2018-2023)
4.2 Global Faecal Microbiota Transplant(FMT) Therapy Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Application (2018-2023)
5.2 Global Faecal Microbiota Transplant(FMT) Therapy Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2018-2029)
6.2 North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2018-2029)
6.3 North America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country
6.3.1 North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Country (2018-2029)
6.3.2 United States Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
6.3.3 Canada Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
6.3.4 Mexico Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2018-2029)
7.2 Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2018-2029)
7.3 Europe Faecal Microbiota Transplant(FMT) Therapy Market Size by Country
7.3.1 Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Country (2018-2029)
7.3.2 Germany Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
7.3.3 France Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
7.3.5 Russia Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
7.3.6 Italy Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size by Region
8.3.1 Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Region (2018-2029)
8.3.2 China Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
8.3.3 Japan Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
8.3.4 South Korea Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
8.3.5 India Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
8.3.7 Australia Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2018-2029)
9.2 South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2018-2029)
9.3 South America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country
9.3.1 South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Country (2018-2029)
9.3.2 Brazil Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
9.3.3 Argentina Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Size by Country
10.3.1 Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Country (2018-2029)
10.3.2 Turkey Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
10.3.4 UAE Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Faecal Microbiota Transplant(FMT) Therapy Market Drivers
11.2 Faecal Microbiota Transplant(FMT) Therapy Market Restraints
11.3 Faecal Microbiota Transplant(FMT) Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Faecal Microbiota Transplant(FMT) Therapy Industry Chain
12.2 Faecal Microbiota Transplant(FMT) Therapy Upstream Analysis
12.3 Faecal Microbiota Transplant(FMT) Therapy Midstream Analysis
12.4 Faecal Microbiota Transplant(FMT) Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Enterome Bioscience Company Information, Head Office, and Major Competitors
Table 6. Enterome Bioscience Major Business
Table 7. Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
Table 8. Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Enterome Bioscience Recent Developments and Future Plans
Table 10. Rebiotix Company Information, Head Office, and Major Competitors
Table 11. Rebiotix Major Business
Table 12. Rebiotix Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
Table 13. Rebiotix Faecal Microbiota Transplant(FMT) Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Rebiotix Recent Developments and Future Plans
Table 15. Ritter Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 16. Ritter Pharmaceuticals Major Business
Table 17. Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
Table 18. Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Ritter Pharmaceuticals Recent Developments and Future Plans
Table 20. Finch Therapeutics Company Information, Head Office, and Major Competitors
Table 21. Finch Therapeutics Major Business
Table 22. Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
Table 23. Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Finch Therapeutics Recent Developments and Future Plans
Table 25. Crestovo Company Information, Head Office, and Major Competitors
Table 26. Crestovo Major Business
Table 27. Crestovo Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
Table 28. Crestovo Faecal Microbiota Transplant(FMT) Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Crestovo Recent Developments and Future Plans
Table 30. Maat Pharma Company Information, Head Office, and Major Competitors
Table 31. Maat Pharma Major Business
Table 32. Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
Table 33. Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Maat Pharma Recent Developments and Future Plans
Table 35. Seres Therapeutics Company Information, Head Office, and Major Competitors
Table 36. Seres Therapeutics Major Business
Table 37. Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
Table 38. Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Seres Therapeutics Recent Developments and Future Plans
Table 40. Second Genome Company Information, Head Office, and Major Competitors
Table 41. Second Genome Major Business
Table 42. Second Genome Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
Table 43. Second Genome Faecal Microbiota Transplant(FMT) Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Second Genome Recent Developments and Future Plans
Table 45. OpenBiome Company Information, Head Office, and Major Competitors
Table 46. OpenBiome Major Business
Table 47. OpenBiome Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
Table 48. OpenBiome Faecal Microbiota Transplant(FMT) Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. OpenBiome Recent Developments and Future Plans
Table 50. MicroBiome Therapeutics Company Information, Head Office, and Major Competitors
Table 51. MicroBiome Therapeutics Major Business
Table 52. MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
Table 53. MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. MicroBiome Therapeutics Recent Developments and Future Plans
Table 55. Global Faecal Microbiota Transplant(FMT) Therapy Revenue (USD Million) by Players (2018-2023)
Table 56. Global Faecal Microbiota Transplant(FMT) Therapy Revenue Share by Players (2018-2023)
Table 57. Breakdown of Faecal Microbiota Transplant(FMT) Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Faecal Microbiota Transplant(FMT) Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 59. Head Office of Key Faecal Microbiota Transplant(FMT) Therapy Players
Table 60. Faecal Microbiota Transplant(FMT) Therapy Market: Company Product Type Footprint
Table 61. Faecal Microbiota Transplant(FMT) Therapy Market: Company Product Application Footprint
Table 62. Faecal Microbiota Transplant(FMT) Therapy New Market Entrants and Barriers to Market Entry
Table 63. Faecal Microbiota Transplant(FMT) Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value (USD Million) by Type (2018-2023)
Table 65. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value Share by Type (2018-2023)
Table 66. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value Forecast by Type (2024-2029)
Table 67. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2018-2023)
Table 68. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value Forecast by Application (2024-2029)
Table 69. North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 70. North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 71. North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 72. North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 73. North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 74. North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 75. Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 78. Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 79. Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 82. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 83. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 84. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 85. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 86. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 87. South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 88. South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 89. South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 90. South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 91. South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 92. South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 94. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 95. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 96. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 97. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 98. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 99. Faecal Microbiota Transplant(FMT) Therapy Raw Material
Table 100. Key Suppliers of Faecal Microbiota Transplant(FMT) Therapy Raw Materials
Table 1. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Enterome Bioscience Company Information, Head Office, and Major Competitors
Table 6. Enterome Bioscience Major Business
Table 7. Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
Table 8. Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Enterome Bioscience Recent Developments and Future Plans
Table 10. Rebiotix Company Information, Head Office, and Major Competitors
Table 11. Rebiotix Major Business
Table 12. Rebiotix Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
Table 13. Rebiotix Faecal Microbiota Transplant(FMT) Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Rebiotix Recent Developments and Future Plans
Table 15. Ritter Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 16. Ritter Pharmaceuticals Major Business
Table 17. Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
Table 18. Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Ritter Pharmaceuticals Recent Developments and Future Plans
Table 20. Finch Therapeutics Company Information, Head Office, and Major Competitors
Table 21. Finch Therapeutics Major Business
Table 22. Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
Table 23. Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Finch Therapeutics Recent Developments and Future Plans
Table 25. Crestovo Company Information, Head Office, and Major Competitors
Table 26. Crestovo Major Business
Table 27. Crestovo Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
Table 28. Crestovo Faecal Microbiota Transplant(FMT) Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Crestovo Recent Developments and Future Plans
Table 30. Maat Pharma Company Information, Head Office, and Major Competitors
Table 31. Maat Pharma Major Business
Table 32. Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
Table 33. Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Maat Pharma Recent Developments and Future Plans
Table 35. Seres Therapeutics Company Information, Head Office, and Major Competitors
Table 36. Seres Therapeutics Major Business
Table 37. Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
Table 38. Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Seres Therapeutics Recent Developments and Future Plans
Table 40. Second Genome Company Information, Head Office, and Major Competitors
Table 41. Second Genome Major Business
Table 42. Second Genome Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
Table 43. Second Genome Faecal Microbiota Transplant(FMT) Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Second Genome Recent Developments and Future Plans
Table 45. OpenBiome Company Information, Head Office, and Major Competitors
Table 46. OpenBiome Major Business
Table 47. OpenBiome Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
Table 48. OpenBiome Faecal Microbiota Transplant(FMT) Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. OpenBiome Recent Developments and Future Plans
Table 50. MicroBiome Therapeutics Company Information, Head Office, and Major Competitors
Table 51. MicroBiome Therapeutics Major Business
Table 52. MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product and Solutions
Table 53. MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. MicroBiome Therapeutics Recent Developments and Future Plans
Table 55. Global Faecal Microbiota Transplant(FMT) Therapy Revenue (USD Million) by Players (2018-2023)
Table 56. Global Faecal Microbiota Transplant(FMT) Therapy Revenue Share by Players (2018-2023)
Table 57. Breakdown of Faecal Microbiota Transplant(FMT) Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Faecal Microbiota Transplant(FMT) Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 59. Head Office of Key Faecal Microbiota Transplant(FMT) Therapy Players
Table 60. Faecal Microbiota Transplant(FMT) Therapy Market: Company Product Type Footprint
Table 61. Faecal Microbiota Transplant(FMT) Therapy Market: Company Product Application Footprint
Table 62. Faecal Microbiota Transplant(FMT) Therapy New Market Entrants and Barriers to Market Entry
Table 63. Faecal Microbiota Transplant(FMT) Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value (USD Million) by Type (2018-2023)
Table 65. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value Share by Type (2018-2023)
Table 66. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value Forecast by Type (2024-2029)
Table 67. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2018-2023)
Table 68. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value Forecast by Application (2024-2029)
Table 69. North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 70. North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 71. North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 72. North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 73. North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 74. North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 75. Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 78. Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 79. Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 82. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 83. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 84. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 85. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 86. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 87. South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 88. South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 89. South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 90. South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 91. South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 92. South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 94. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 95. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 96. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 97. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 98. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 99. Faecal Microbiota Transplant(FMT) Therapy Raw Material
Table 100. Key Suppliers of Faecal Microbiota Transplant(FMT) Therapy Raw Materials
LIST OF FIGURES
Figure 1. Faecal Microbiota Transplant(FMT) Therapy Picture
Figure 2. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Type in 2022
Figure 4. Oral
Figure 5. Enema
Figure 6. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Application in 2022
Figure 8. Clostridioides Difficile Infection(CDI) Picture
Figure 9. Digestive System Disease Picture
Figure 10. Nervous System Disease Picture
Figure 11. Others Picture
Figure 12. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Faecal Microbiota Transplant(FMT) Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Region in 2022
Figure 17. North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Faecal Microbiota Transplant(FMT) Therapy Revenue Share by Players in 2022
Figure 23. Faecal Microbiota Transplant(FMT) Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Faecal Microbiota Transplant(FMT) Therapy Market Share in 2022
Figure 25. Global Top 6 Players Faecal Microbiota Transplant(FMT) Therapy Market Share in 2022
Figure 26. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value Share by Type (2018-2023)
Figure 27. Global Faecal Microbiota Transplant(FMT) Therapy Market Share Forecast by Type (2024-2029)
Figure 28. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value Share by Application (2018-2023)
Figure 29. Global Faecal Microbiota Transplant(FMT) Therapy Market Share Forecast by Application (2024-2029)
Figure 30. North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 40. France Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Region (2018-2029)
Figure 47. China Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 50. India Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 64. Faecal Microbiota Transplant(FMT) Therapy Market Drivers
Figure 65. Faecal Microbiota Transplant(FMT) Therapy Market Restraints
Figure 66. Faecal Microbiota Transplant(FMT) Therapy Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Faecal Microbiota Transplant(FMT) Therapy in 2022
Figure 69. Manufacturing Process Analysis of Faecal Microbiota Transplant(FMT) Therapy
Figure 70. Faecal Microbiota Transplant(FMT) Therapy Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Faecal Microbiota Transplant(FMT) Therapy Picture
Figure 2. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Type in 2022
Figure 4. Oral
Figure 5. Enema
Figure 6. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Application in 2022
Figure 8. Clostridioides Difficile Infection(CDI) Picture
Figure 9. Digestive System Disease Picture
Figure 10. Nervous System Disease Picture
Figure 11. Others Picture
Figure 12. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Faecal Microbiota Transplant(FMT) Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Region in 2022
Figure 17. North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Faecal Microbiota Transplant(FMT) Therapy Revenue Share by Players in 2022
Figure 23. Faecal Microbiota Transplant(FMT) Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Faecal Microbiota Transplant(FMT) Therapy Market Share in 2022
Figure 25. Global Top 6 Players Faecal Microbiota Transplant(FMT) Therapy Market Share in 2022
Figure 26. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value Share by Type (2018-2023)
Figure 27. Global Faecal Microbiota Transplant(FMT) Therapy Market Share Forecast by Type (2024-2029)
Figure 28. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value Share by Application (2018-2023)
Figure 29. Global Faecal Microbiota Transplant(FMT) Therapy Market Share Forecast by Application (2024-2029)
Figure 30. North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 40. France Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Region (2018-2029)
Figure 47. China Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 50. India Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 64. Faecal Microbiota Transplant(FMT) Therapy Market Drivers
Figure 65. Faecal Microbiota Transplant(FMT) Therapy Market Restraints
Figure 66. Faecal Microbiota Transplant(FMT) Therapy Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Faecal Microbiota Transplant(FMT) Therapy in 2022
Figure 69. Manufacturing Process Analysis of Faecal Microbiota Transplant(FMT) Therapy
Figure 70. Faecal Microbiota Transplant(FMT) Therapy Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
